🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Status
Completed
Location
Hospital Universitario Príncipe de Asturias
Start Date
2020-11-04
Trial ID
NCT04687761
Treatments Being Tested
The objective of this study is to determine the safety and efficacy of Azac...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09
Trial ID
NCT00413478
Treatments Being Tested
Decitabine is a hypomethylating agent that has shown significant anti-leuke...
Status
Completed
Location
UF Health Shands Hospital
Start Date
2014-10
Trial ID
NCT02264873
Treatments Being Tested
This is a study to assess the safety of increasing dose levels of bexmarili...
Status
Active Not Recruiting
Location
City of Hope National Medical Center
Start Date
2022-06-02
Trial ID
NCT05428969
Treatments Being Tested
This study is designed to examine blood levels of ASTX727, a fixed-dose com...
Status
Completed
Location
Roswell Park
Start Date
2018-11-08
Trial ID
NCT03813186
Treatments Being Tested
This is a Phase 1, open-label, multicenter, dose-escalation \& expansion st...
Status
Unknown
Location
The First Affiliated Hospital of Nanchang University
Start Date
2023-02-14
Trial ID
NCT05641259
Treatments Being Tested
The purpose of this research study is to test the safety and efficacy of a ...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-02-02
Trial ID
NCT07148180
Treatments Being Tested
This Phase 1/2 study will evaluate the safety, efficacy, PK, and PD of FT-2...
Status
Completed
Location
UCLA Medical Center
Start Date
2016-04-30
Trial ID
NCT02719574
Treatments Being Tested
This is a Phase I/II clinical study to determine the maximum tolerated dose...
Status
Terminated
Location
Research Site
Start Date
2017-07-31
Trial ID
NCT03217838
Treatments Being Tested
This is a Phase 1 dose-escalation study of PRT1419, a myeloid cell leukemia...
Status
Terminated
Location
Mid Florida Hematology and Oncology Center
Start Date
2022-03-22
Trial ID
NCT05107856
Treatments Being Tested